Y Zheng, S Ye, S Huang, Y Cheng, Y Zhang… - Advanced …, 2024 - Wiley Online Library
Acquired resistance represents a critical clinical challenge to molecular targeted therapies
such as tyrosine kinase inhibitors (TKIs) treatment in hepatocellular carcinoma (HCC) …